NDA 207809 describes MELPHALAN, which is a drug marketed by
Alvogen,
Actavis Llc,
Almaject,
Arthur Grp,
Bpi Labs,
Dr Reddys,
Fresenius Kabi Usa,
Gland Pharma Ltd,
Hikma,
Ingenus Pharms Llc,
Meitheal,
Mylan Institutional,
Par Sterile Products,
Sagent Pharms Inc,
Uswm, and
Apotex, and is included in eighteen NDAs. It is available from
one supplier. There is one patent protecting this drug. Additional details are available on the
MELPHALAN profile page.
The generic ingredient in MELPHALAN is
melphalan hydrochloride. There are twelve
drug master file entries for this compound. Fourteen
suppliers are listed for this compound. Additional details are available on the
melphalan hydrochloride profile page.